ArticleJournal of gastrointestinal oncology2013

The role of EGFR monoclonal antibodies (MoABs) cetuximab/panitumab, and BRAF inhibitors in BRAF mutated colorectal cancer.

Shan Muhammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.